Trichloroethylene (TCE), an industrial chemical and environmental contaminant, is a human carcinogen. Reactive metabolites are implicated in renal carcinogenesis associated with TCE exposure, yet the toxicity mechanisms of these metabolites and their contribution to cancer and other adverse effects remain unclear. We employed an integrated functional genomics approach that combined functional profiling studies in yeast and avian DT40 cell models to provide new insights into the specific mechanisms contributing to toxicity associated with TCE metabolites. Genome-wide profiling studies in yeast identified the error-prone translesion synthesis (TLS) pathway as an import mechanism in response to TCE metabolites. The role of TLS DNA repair was further confirmed by functional profiling in DT40 avian cell lines, but also revealed that TLS and homologous recombination DNA repair likely play competing roles in cellular susceptibility to TCE metabolites in higher eukaryotes. These DNA repair pathways are highly conserved between yeast, DT40, and humans. We propose that in humans, mutagenic TLS is favored over homologous recombination repair in response to TCE metabolites. The results of these studies contribute to the body of evidence supporting a mutagenic mode of action for TCE-induced renal carcinogenesis mediated by reactive metabolites in humans. Our approach illustrates the potential for highthroughput in vitro functional profiling in yeast to elucidate toxicity pathways (molecular initiating events, key events) and candidate susceptibility genes for focused study.
Trichloroethylene (TCE) was introduced in the 1920's as a replacement for chloroform and ether in various industrial processes (Bakke et al., 2007; Guha et al., 2012) . Although TCE use has declined substantially, it still remains an environmental health hazard decades after its introduction (Rusyn et al., 2014) . The Environmental Protection Agency and the International Agency for Research on Cancer classify TCE as a human carcinogen via all routes of exposure. There is strong evidence from rodent and epidemiological studies associating TCE exposure with renal cancer and to a lesser extent, liver cancer and nonHodgkin lymphoma (Chiu et al., 2013; Guha et al., 2012; Karami et al., 2012 Karami et al., , 2013 Rusyn et al., 2014) .
TCE undergoes a complex biotransformation via 2 metabolic pathways, cytochrome P450 (CYP)-dependent oxidation and glutathione (GSH) conjugation (Lash et al., 2000; Rusyn et al., 2014) . Oxidative metabolism, occurs primarily in the liver in both rodents and humans but has been observed in the lungs, testses, and kidney to lesser extents (Rusyn et al., 2014) . Multiple CYPs including CYP2E1, CYP1A1/2, CYP3A4, CYP2A6 participate in TCE metabolism (Chiu et al., 2006; Lash et al., 2000) . The initial CYP reaction yields a chloral hydrate metabolite, which is reduced to trichloroethanol (TCOH) by alcohol dehydrogenase (ADH) or oxidized by aldehyde dehydrogenase (ALDH) to form trichloroacetic acid (TCA) and dichloroacetic acid (DCA). Trichloroethanol can undergo glucuronidation, to form a TCOH-glucuronide, a major metabolite found in urine (Kim et al., 2009b) . Oxidative metabolites are cytotoxic, induce oxidative stress, and alter DNA methylation (Rusyn et al., 2014) . However, GSH conjugation of TCE also occurs, likely secondary to saturation of CYP-mediated metabolism, by GSH S-transferase (GST) to form the dichlorovinyl GSH (DCVG) conjugate (Kim et al., 2009a) . In the kidney, DCVG is metabolized by gamma-glutamyl transferase (GGT) and cysteine conjugate dipeptidases to form the penultimate reactive metabolite dichlorovinyl cysteine (DCVC). DCVC can be further metabolized by cysteine conjugate beta-lyase, N-acetylase or flavin-containing monooxygenase to form reactive intermediates (Goeptar et al., 1995; Lash et al., 2000 Lash et al., , 2007 . TCE renal toxicity is dependent on the formation of the reactive DCVC metabolite . Increased levels of the kidney injury molecule, a biomarker of nephrotoxicity, observed in, workers exposed to TCE suggest that chronic, low level exposures to TCE can cause renal damage in humans (Moore et al., 2010) . However, the underlying mechanisms contributing to kidney toxicity and renal carcinogenesis remain an area of active interest.
In this study, we employed a comprehensive functional genomics approach, including functional profiling studies in yeast and avian cell models to elucidate mechanisms that contribute to TCE-associated renal toxicity and identify potential candidate susceptibility genes for further study in genetic analyses. Functional profiling in Saccharomyces cerevisiae (budding yeast) is a well-established, unbiased, and high-throughput approach used to identify toxicity mechanisms and candidate susceptibility genes for several environmental contaminants (Gayt an and Vulpe, 2014; Jo et al., 2009b; North et al., 2009 North et al., , 2011 North and Vulpe, 2010) . Similarly, avian DT40 cells lacking specific DNA repair pathways, have been used to identify mechanisms of genotoxicity (Evans et al., 2010) . Our findings revealed 2 specific DNA repair pathways that likely modulate TCE renal toxicity, mutagenesis, and carcinogenesis in humans.
MATERIALS AND METHODS
Chemical reagents. DCVC conjugate was a generous gift from Professor A. Elfarra at the University of Wisconsin, Madison. Stock solutions were prepared in sterile Milli-Q water (Millipore, Billerica, Massachusetts) and stored at À20 C until use. All yeast reagents were purchased from commercial suppliers.
Yeast strains, culture, and plasmids. The diploid yeast deletion strains used for functional profiling and confirmation analyses were of the BY4743 background (MATa/MATa his3D1/his3D1 leu2D0/leu2D0 lys2D0/LYS2 MET15/met15D0 ura3D0/ura3D0, Invitrogen). For deletion pool growth, cells were grown in liquid rich media (1% yeast extract, 2% peptone, 2% dextrose, YPD). All assays were performed in liquid YPD at 30 C with shaking at 200 rpm, as previously detailed in (Gayt an et al., 2013a,b) . Deletion strains were authenticated by the Saccharomyces Genome Deletion Project Consortium using PCR and appropriate auxotrophic markers.
Functional profiling of the yeast genome. Growth of the deletion pools, genomic DNA extraction, barcode amplification, Affymetrix TAG4 array hybridization, and differential strain sensitivity analysis (DSSA) were performed as described in Jo et al. (2009a) . Briefly, pools of yeast homozygous diploid deletion mutants (n ¼ 4607) were grown for 5 generations in the presence of 18, 9, or 4.5 lM DCVC, the IC 20 , 50% IC 20 , and 25% IC 20 , respectively. Three biological replicates with 3 technical replicates at each dose were collected for analysis. Genomic DNA was extracted for all samples using the YPER kit (Pierce Biotechnology). The DNA sequences unique to each strain (barcodes) were amplified by PCR and hybridized to TAG4 arrays (Affymetrix), which were incubated overnight, stained, and then scanned at an emission wavelength of 560 nm with a GeneChip Scanner (Affymetrix). Microarray data available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.p8k18
Differential strain sensitivity analysis. Raw TAG4 array data were processed and log 2 transformed for DSSA analysis. Log 2 values from each treatment array were matched to data from 12 controls for analysis. Treatment-control pairs were normalized with locally weighted scatterplot smoothing (global normalization), and the difference in growth between strains was identified using an alpha-outlier approach (Loguinov et al., 2004) . Data from 3 biological replicates were combined, resulting in 36 treatment-control data pairs per treatment group. Significant yeast deletion strains were statistically inferred by an exact binomial test, with the assumption that the outcomes for each gene in all treatment-control pairs were independent binary variables with the same probability of success for all Bernoulli trials. For a particular gene n, outcomes were considered as "successful" if they were significant in the outlier analysis with q-values 0.05 in each of all effective pairs with log 2 ratios of the same sign, simultaneously (Loguinov et al., 2004) . The corresponding raw p values based on the exact binomial test were then corrected for multiplicity of comparisons using a q-value approach and only the genes with q-value .05 were considered for further analysis. A fitness score was calculated for each yeast deletion strain and is defined as the difference between mean log 2 ratios of DCVC treated and untreated control (avg[log 2 {YjX ¼ treated}]Àavg[log 2 {YjX ¼ control}]) (Gayt an et al., 2013a; North et al., 2011; O'Connor et al., 2012) . A negative fitness score indicates the sensitivity of a strain to DCVC treatment and a positive fitness score indicates resistance to DCVC treatment. The fitness score serves as an indicator of the effect of DCVC on the growth of the yeast deletion strain.
Gene ontology enrichment analysis. All 56 strains identified as sensitive by DSSA were used for enrichment analysis. Significantly overrepresented gene ontology (GO) and MIPS (Munich Information Center for Protein Sequences) categories (Mewes et al., 2002) were identified by a hypergeometric distribution using the online resource, FunSpec (http://funspec.med.utoronto. ca/; last accessed June 2017) with a p-value cutoff of .05 and Bonferroni correction (Robinson et al., 2002) .
Yeast confirmation assays by flow cytometry. A flow cytometry based competitive growth assay was performed to confirm sensitivity of strains identified by DSSA. Briefly, green fluorescent protein (GFP)-tagged wild-type and untagged mutant strains were grown overnight in YPD, diluted to 0.5 OD600, and mixed in approximately equal numbers as previously described (North et al., 2011) 25 DT40 cell lines were available and viable for screening. The following mutants were kindly provided:
, and PCNA K164R (Dr Jun Nakamura and Dr James Swenberg, University of North Carolina at Chapel Hill). Disruption of the gene in each mutant was confirmed by the disappearance of either target mRNA or protein (references in Supplementary Table 3 ). PD20 is a human lymphoblastoid cell line derived from an individual with a Fanconi anemia (FA) complementation group D2 (FANCD2) null mutation and the PD20D2 cell line was generated from the PD20 cell line to ectopically express the FANCD2 protein by the original lab (Ren et al., 2013) and kindly provided by Dr Luoping Zhang, UC Berkeley. The absence of FANCD2 protein in PD20 cells, and its presence in PD20-D2 cells was determined by protein immunoblot (Zhang lab, during 2012-13). Both cell lines were cultured in RPMI 1640 and 15% fetal bovine serum and 1% PS in humidified incubators at 37 C and 5% CO 2 . The TK6 þ/-human lymphoblast cell line was purchased from ATCC, authenticated by STR DNA profiling (ATCC) and kindly provided by Dr. Rebecca Fry, University of Chapel Hill. TK6 þ/À cells were cultured in RPMI 1640 with 10% FBS in humidified incubators at 37 C and 5% CO 2 .
Viability assays. DT40 viability assays were conducted as outlined previously (Ridpath et al., 2011) using wild-type and DT40 knockout strains. Briefly, 2.5 Â 10 2 cells were seeded in 96-well plates and treated for 48-72 h with DCVC or cisplatin prepared in PBS. For PD20 viability studies, cells were seeded at 1 Â 10 4 in 96-well plates and treated with DCVC for 3 days. The XTT assay was conducted per kit directions (ATCC). Viability was measured as a function of absorbance at 450 nm and normalized to untreated controls. IC 50 values were used to calculate a viability ratio for mutants versus wild-type. Sensitivity to DCVC is defined as a viability ratio<1 and resistance is defined as a viability ratio >1.
Thymidine kinase assay. TK6 þ/À human lymphoblastoid cells were seeded at $2 Â 10 6 cells/exposure and treated in duplicate for each DCVC dose for 24 h. Subsequently, cells were plated in 96-well microtiter plates at 40 000 cells per well in medium containing trifluorothymidine (TFT). Efficiency plates were seeded with 2 cells per well in medium without TFT. The plates were incubated at 37 C with 5% CO 2 . After 6 weeks, the presence or absence of colonies in each well was measured. Colony growth was measured by XTT assay (ATCC) and mutation frequency was calculated as outlined in Caspary et al. (1988) .
RESULTS

Dose Response of TCE Metabolites in Yeast
Initially we conducted dose response experiments on GSH conjugated (DCVG and DCVC) metabolites. We determined the IC 20 of DCVC in S. cerevisiae to be 18 lM by growth curve analysis (Supplementary Figure 1) . In humans, DCVG is metabolized to DCVC by GGT. The yeast homolog of human GGT is ECM38 and we examined ECM38 mutants to confirm metabolic activation of TCE metabolites in yeast. In ECM38 mutants, DCVG toxicity was rescued across all doses of DCVG (Supplementary Figure 1) . In contrast, mutants deficient in putative beta lyases, which can metabolize DCVC to other reactive metabolites, exhibited toxicity similar to wild-type. These results suggest that in yeast, conversion to DCVC is required and responsible for toxicity. This observation is consistent with previous in vitro studies using chemical GGT inhibitors, which show that DCVG requires processing by GGT to form DCVC and that DCVC is the substrate ultimately responsible for toxicity in human proximal tubule cells (McGoldtrick et al., 2003) . However, we cannot rule out the role of other reactive intermediates generated from DCVG or DCVC in contributing to toxicity in yeast. We focused our profiling studies on DCVC, the penultimate metabolite in human renal toxicity.
A Genome-Wide Screen Identifies Mutants With Altered Growth in the Presence of the TCE Metabolite DCVC Pools of yeast homozygous diploid deletion mutants (n ¼ 4607) were grown for 5 generations and treated with 18, 9, or 4.5 lM DCVC, the IC 20 , 50% IC 20 , and 25% IC 20 , respectively. A DSSA identified 56 strains as sensitive and 155 mutants as resistant to at least 1 dose of DCVC and 211 genes were identified in total. Figure  2 ). Analysis of a RAD30 mutant was used as a negative control as it was not identified in the genome-wide profiling study and is involved in DNA repair. We found that specific nucleases involved in nucleotide excision repair (NER) (PSO2, RAD1, RAD10)
were also necessary in the cellular response to DCVC (Figure 1 and Supplementary Figure 2 ). Together these results confirmed the role of TLS and NER genes in response to DCVC in S. cerevisiae. The functional profile generated by DCVC is consistent with reported yeast functional profiles of DNA damaging agents (Lee et al., 2005) . Yeast and in vitro mammalian studies have shown that TLS NER, and homologous recombination (HR) mutants exhibit sensitivity to crosslinking agents such as cisplatin, nitrogen mustards, and mitomycin C (Lee et al., 2005; McHugh et al., 2000) . Similarly, we identified several genes from these pathways as sensitive to DCVC exposure. Given the similarity between the genetic profile of DCVC and the profiles of known interstrand crosslinking agents, we initially hypothesized that DCVC induced DNA crosslink damage that would require interstrand crosslink (ICL) repair. Significance values were calculated by Student's t-test, where ***p < .001, **p < .01, *p < .05 for DCVC-treated wild-type versus mutant.
Enrichment Analysis Identifies Attributes Necessary for DCVC Tolerance
The set of 56 strains displaying sensitivity to DCVC treatments were analyzed with FunSpec software for GO enrichment of biological processes. Significantly overrepresented GO categories were identified at corrected p-value of < .05. DCVC sensitive strains were enriched in response to DNA damage stimulus, error-free TLS, and error-free TLS biological processes and we focused on these DNA damage and repair pathways for further study (Table 2) . DNA repair was the most significantly overrepresented MIPS category for DCVC. Together these results suggest DCVC causes DNA damage and TLS repair likely plays a predominant role in responding to this damage.
DT40 Mutants Deficient in Error-Prone DNA Repair Are Most Sensitive to DCVC
To assess if our findings in yeast extended to more complex eukaryotes, we evaluated the sensitivity to DCVC in a panel 24 of isogenic DT40 avian cell lines, each lacking a different DNA repair genes and one mutant PCNAK164R strain with a missense mutation at lysine 164, an important site for posttranslation modifications that mediate DNA repair. The DT40 panel represented DNA repair pathways, such as TLS, NER, HR, and ICL repair, which are highly conserved in humans (Ji et al., 2009) (Supplementary Table 3 ). A total of 4 yeast genes (3 sensitive and 1 resistant) identified from our yeast profiling studies had DT40 homologs available for screening. The remaining DT40 cell lines were DNA repair genes not identified in yeast experiments. With this panel we confirmed the important and conserved role of TLS repair in response to DCVC and propose a mechanism of genotoxicity that is likely relevant in humans. Wild-type and 25 mutant DT40 cell lines were treated with DCVC or the interstrand crosslinking agent cisplatin (positive control) to determine dose response and IC 50 values. All individual dose response curves can be found in Supplementary Figure  3 . Wild-type DT40 cells showed a significant decrease in viability in the presence of DCVC and the IC 50 was determined to be 3 lM. A comparison of IC 50 values revealed cell lines deficient in TLS exhibited a significant decrease in viability compared with wild-type cells (Figure 2 and Supplementary Figure 3) . DCVC was 10Â more toxic in TLS mutants compared with wild-type, with IC 50 values between 300 nM and 1.6 lM. The TLS mutants REV1
, and PCNAK164R all exhibited greater sensitivity to DCVC compared with wild-type cells and this is consistent with yeast profiling results (Figure 2 and Supplementary Figure  3) . The viability of mutants deficient in NER, base excision repair (BER), nonhomologous end joining (NHEJ), and DNA checkpoints were unchanged by DCVC exposure (Supplementary Figure 3) . In contrast, the viability of some HR deficient cell lines increased compared with wild-type and were 10Â less sensitive with IC 50 values between 13 and 36 lM for DCVC (Supplementary Figure 3) . When compared with the crosslinking agent cisplatin, DCVC was 10-100Â less cytotoxic in all mutant cell lines tested (Figure 2) . DT40 Mutants defective in the initial damage recognition steps of the TLS pathway, PCNAK164R, REV1, and RAD18, exhibited the greatest sensitivity to DCVC, suggesting critical roles in response to DCVC damage. TLS is an error-prone repair mechanism that tolerates and bypasses DNA damage during replication by recruiting low fidelity polymerases to bypass DNA lesions and prevent fork stalling at the expense of genomic stability (Andersen et al., 2008) . The moderate sensitivity of RAD18 -/-cells to DCVC is consistent with RAD18-independent ubiquitination of PCNA observed in DT40 cells exposed to DNA damaging agents (Simpson et al., 2006) . The role of error-prone TLS is further supported by our findings from thymidine kinase (TK) mutation assays in human lymphoblast cells treated with DCVC showing a significant increase in mutation frequency compared with untreated controls (Supplementary Table 2 ) and is consistent with prior studies demonstrating DCVC as a mutagen in bacterial assay systems (Irving and Elfarra, 2013) . Mutation frequency in DCVC exposures increased between 1.8-and 2.3-fold compared with untreated controls. The sensitivity of key DT40 translesion mutants and increased mutation frequency demonstrates an important role for this error-prone pathway in modulating DCVC genotoxicity.
DT40 Mutants Deficient in ICL Repair Are Not Sensitive to DCVC
Given the similarity between the genetic profile of DCVC and the profiles of known interstrand crosslinking agents in yeast, we expected mutants deficient in ICL repair to exhibit sensitivity to DCVC. Among the family of FA repair genes, FANCD2 is indispensable for recombination dependent ICL repair (Huang et al., 2013) . DT40 FANCD2 -/-mutants treated with DCVC did not exhibit sensitivity in contrast to the known crosslink agent, cisplatin (Figure 2 ). Furthermore, we did not observe sensitivity to DCVC in human PD20 cells, which lack a functional FANCD2 protein (Supplementary Figure 4) . These findings suggest DCVC likely does not induce DNA crosslinks, though our studies do not rule out a compensatory or minor role for FA mediated repair of DCVC-induced damage.
DT40 HR Mutants Are Resistant to DCVC
Interestingly, DT40 cells deficient in HR showed increased cellular viability in response to DCVC. Most notable was the resistance exhibited by BRCA1 -/-and RAD51D -/-cell lines in response to DCVC. This is in contrast to the sensitivity exhibited by yeast RAD51 mutants in response to DCVC exposure. RAD54 -/-and A list of all strains (n ¼ 56) exhibiting sensitivity to one of the 3 doses of DCVC was entered into the FunSpec tool and analyzed for overrepresented biological attributes (see "Materials and Methods" Section).
b Number of genes in category identified as sensitive to DCVC.
c Number of genes in GO or MIPS category.
RAD52
-/-cells exhibited moderate increases in viability in response to DCVC (Supplementary Figure 3) . The moderate resistance observed in RAD54 -/-cells is consistent with the response observed in yeast rad16 mutants; both yeast and DT40 genes contain sequence similarity, although it is unclear whether DCVC resistance is conferred by similar functions. The functional redundancy of HR mutants (RAD54, RAD52, BRCA2) could explain the lack of sensitivity observed in our DT40 studies and has been reported previously in Shrivastav et al. (2008) . Recombination is tightly regulated by a variety of factors, including RecQ helicases, which prevent inappropriate recombination that can interfere with postreplication repair or form cytotoxic intermediates (Brosh, 2013; Machwe et al., 2011; Mao et al., 2010) . WRN -/-and BLM -/-cells lack the Werner's syndrome and Bloom's Syndrome RecQ helicases, respectively. Both play roles in regulating the HR response in overcoming replication blocks and resolving complex DNA structures (Brosh, 2013) . We observed mild sensitivity in WRN -/-cells exposed to DCVC, suggesting WRN may play a minor role in regulating recombination repair of DCVC damage encountered during replication (Figure 2 and Supplementary Figure 3) . The functional redundancy of WRN and BLM helicases could explain the mild sensitivity of WRN -/-cells observed in our studies and is in agreement with previous findings showing moderate sensitivity to a variety of DNA damaging agents (Brosh, 2013; Kawabe et al., 2006; Machwe et al., 2011; Mao et al., 2010) . Our findings of HR resistance suggest DCVC may induce recombination intermediates that are unfavorable and detrimental to the restart of replication and viability. Sensitivity to DCVC or cisplatin is defined as a viability ratio <1 and resistance is defined as a viability ratio >1. Cisplatin exposures in BLM and REV1 mutants were not viable and are not included. Values are mean 6 SE; n ! 3 for each measurement. ICL, interstrand crosslink repair; HR, homologous recombination; TLS, translesion synthesis repair.
DISCUSSION TCE exposure is a risk factor for renal cancer but the underlying genetic risk factors remain an area of active interest. By using genomic profiling in budding yeast and DT40 cell lines, we identified a conserved mutagenic mechanism that may underlie TCE genotoxicity and contribute to renal carcinogenesis, as well as, candidate susceptibility genes for further genetic analysis (Table 3 ). The TLS gene RAD18, which is upstream in initiating TLS repair and the TLS polymerase REV1 were identified as important targets in response to DCVC in both yeast and DT40 studies, while the DNA helicase, WRN was identified as a target in DT40 analyses. The increased sensitivity of TLS and WRN mutants and resistance of HR mutants to DCVC observed in DT40 screening suggests TLS repair plays a predominant role in response to DCVC induced damage encountered during replication and is favored over HR repair. The WRN helicase likely modulates TLS-homologous recombination repair dynamics induced by DCVC by aborting RAD51-generated recombination intermediates that potentially form at sites of DCVC damage and consequently, favors TLS ( Figure 3 ). Together this evidence supports the error-prone TLS repair pathway and in turn, DNA damage and mutagenesis as an important and conserved response to DCVC. In the context of the kidney, the predominance of the TLS pathway in maintaining cellular viability in response to DCVC damage at the cost of genome integrity could result in genotoxicity and contribute to renal carcinogenesis associated with TCE exposure. Limitations of our functional screening approach with yeast and DT40 systems include the availability and viability of DT40 strains for all genes identified as sensitive in yeast profiling experiments and species differences in certain DNA repair pathways. In yeast, RAD51 has 3 paralogs, whereas DT40 and mammalian species have 5. Previous studies have shown that DT40 cells deficient in any 1 of the 5 RAD51 paralogs (RAD51B, RAD51C, RAD51D, XRCC2, XRCC3) show a very similar phenotype, such as similar levels of DNA damage sensitivity, suggesting that each paralog is essential for RAD51 function (Qing, et al., 2011) . Interestingly, in our study XRCC2 and XRCC3 mutants exhibited similar phenotypes, but were dissimilar to the resistant phenotype observed in RAD51D mutants (Figure 2 and Supplementary Figure 3) . We speculate that one basis for RAD51 sensitivity in yeast as opposed to RAD51D resistance in DT40 studies is that some of the DCVC-associated DNA adducts are converted into double-strand breaks. HR plays essential roles in double-strand break repair and break-induced replication in yeast; (Symington and Gautier, 2011) whereas, recombination is tightly regulated to prevent inappropriate recombination in mammalian DNA repair (Brosh, 2013; Machwe et al., 2011; Mao et al., 2010) . The resistance observed in DT40 BRCA1 -/-mutants further supports this hypothesis.
BRCA1
-/-mutants showed the greatest resistance to DCVC followed by RAD51D -/-
. BRCA1 serves as a switch between HR and NHEJ repair of double strand breaks. Upon recognition of double strand breaks, BRCA1 acts as a scaffold and recruits DNA repair proteins at the site of damage. BRCA2, along with RAD51D promote assembly of RAD51 onto resected, single stranded DNA to begin HR repair. BRCA1 and BRCA2 do not have homologs in yeast and is another example of species differences in our screens. However, these differences do not diminish the likely role of the conserved pathways identified in this study in modulating DCVC genotoxicity in humans. Further mechanistic studies are needed to parse out how and to what extent these pathways contribute to genomic instability in response to TCE metabolites. PSO2, RAD1, and RAD10 are yeast nucleases that have been shown to resolve DNA structures ie, hairpins in yeast and mammalian systems and implicated in the resection of repair intermediates that can be substrates for HR in yeast (Munari et al., 2013) . These NER nucleases were identified as sensitive to DCVC in yeast profiling, but we were unable to evaluate the conserved role of these NER nucleases in the DT40 model due to the unavailability of mutant cell lines. However, we profiled the available NER DT40 mutant cell lines, XPA À/À and XPG -/-which did not exhibit a response to DCVC that was significantly different from wild-type cells (Figure 2 and Supplementary Figure 3) . The lack of sensitivity in XPA -/ and XPG -/-mutants, critical components of NER, is consistent with a mechanism of nondistorting DNA damage which would be largely undetected by NER and BER repair systems and would not elicit DNA repair checkpoints intended to limit repair during replication. Although the exact form of DNA damage remains unclear, under noncellular conditions, possible DCVC monoadducts with individual nucleobases (Anders, 2004 (Anders, , 2008 have been identified. Individuals with alterations in TLS repair capacity may be more susceptible to genomic instability and renal toxicity induced by TCE metabolites. It was initially reported that TCE exposed workers had increased mutation prevalence in the von Hippel Lindau (VHL) gene with a hotspot at nt454 (codon 81) compared with unexposed cases, suggesting a unique genetic signature for TCE exposure and a mutagenic mode of action in the development of RCC (Brauch et al., 2004) . However, subsequent studies did not observe increased or distinctive VHL mutations among TCE exposed cases compared with unexposed cases (Charbotel et al., 2007; Moore et al., 2011) . Mutations in the hypoxia response regulator and tumor suppressor gene, VHL, and the chromatin remodeling genes PBRM1, BAP1 and SETD2 are recurrent in the main form of clear cell renal cell carcinoma (RCC) (Creighton et al., 2013; Watson et al., 2013) . Unique mutation signatures in these chromatin remodeling susceptibility genes have not been evaluated in the context of TCE exposure and RCC risk. Previously, genes involved in the metabolism of TCE to nephrotoxic intermediates (GSTT1 and CCBL1) have shown to be significantly associated with RCC susceptibility in workers with occupational exposure to TCE (Moore et al., 2010) . Our findings compliment these results and further support GSH conjugated metabolite genotoxicity as a contributing mechanism in renal toxicity and carcinogenesis associated with TCE exposure. Our approach illustrates the potential for high-throughput in vitro functional profiling in yeast to elucidate toxicity pathways (molecular initiating events, key events) and identify potential candidate susceptibility genes for focused study.
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences online. Working model of DCVC mutagenic mechanism. We hypothesize that DCVC causes DNA lesions that do not distort the DNA helix, but do stall the replicative polymerase during DNA replication. We postulate that bypass of these DNA lesions can occur by 2 competitive mechanisms, TLS and HR. TLS can successfully bypass the lesion, but can be error prone and result in mutagenesis at sites of damage. Our findings of increased resistance of HR mutants to DCVC suggests HR repair is detrimental to cell survival perhaps due to formation of unresolved recombination intermediates. Conversely, if TLS is inhibited, cellular survival is reduced; indicating that TLS is the primary mechanism for bypassing DCVC induced damage. The loss of the WRN helicase also reduces viability of DCVC exposed cells, consistent with a role for favoring the TLS pathway.
